💉
Many reports have shown rapid declines of anti-SARS-CoV-2antibodies inconvalescents. It remains unclear how this declineimpacts protection fromreinfection or severity of disease, but initial resultsalso show that T-cell immunitymight be very long-lived. One report by Le Bert andcolleagues shows thatpatients who recovered in 2003 from SARS-CoV-1 infectionharbor SARS-CoV-2cross-reactive T-cells 17 years later.
💉
@icedquinn
Have fun buying into glorified food supplements: "RaDVaC vaccines are complementary to commercial vaccines, and do not preclude the use of other vaccines."
re: 💉
@icedquinn
Technically, they're not allowed to say it works until they get FDA approval. Which they don't. And probably won't ever get.
re: 💉